Sound waves to the brain could ease long COVID fatigue

NCT ID NCT06178952

Recruiting now Symptom relief Sponsor: Medical University of Vienna Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a device that sends gentle sound pulses to the brain can reduce fatigue, brain fog, and mood problems in people with long COVID. 102 adults who have had COVID-19 at least 12 months ago will receive either real or fake (sham) treatment over five sessions. The main goal is to see if the real treatment improves fatigue more than the placebo.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: transcranial pulse stimulation (a device that sends sound waves to the brain)
What this could lead to: If it works, this could offer a new, non-drug way to reduce fatigue and improve thinking and mood in people with long COVID.
What could go wrong: This is an early-stage trial with no prior proof of effectiveness. The sham control means some people may not improve, and benefits may be small or temporary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FATIGUE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fatigue long COVID-19 post-COVID-19 disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FATIGUE POST COVID-19 SYNDROME

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Medical University of Vienna
RECRUITING

Vienna, State of Vienna, 1090, Austria

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.